SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-040285
Filing Date
2022-07-19
Accepted
2022-07-19 16:05:58
Documents
2
Period of Report
2022-07-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 10308
2 POWER OF ATTORNEY ea163020ex24-1_protarather.htm EX-24.1 5576
  Complete submission text file 0001213900-22-040285.txt   17423
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address
Fry Hannah (Reporting) CIK: 0001938146 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36694 | Film No.: 221091628